Previously, we showed that the IGFBP-3 levels in the serum and synovial fluid were significantly higher in patients with RA and had a significantly positive correlation with the ESR and CRP levels that highly correlate with RA disease activity in these patients [8]. This evidence concerns the gene IGFBP3 and rheumatoid arthritis.